GE HealthCare Technologies Inc. (GEHC)
GEHC Stock Price Chart
Explore GE HealthCare Technologies Inc. interactive price chart. Choose custom timeframes to analyze GEHC price movements and trends.
GEHC Company Profile
Discover essential business fundamentals and corporate details for GE HealthCare Technologies Inc. (GEHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
15 Dec 2022
Employees
53.00K
Website
https://www.gehealthcare.comCEO
Peter J. Arduini
Description
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GEHC Financial Timeline
Browse a chronological timeline of GE HealthCare Technologies Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Oct 2025
EPS estimate is $1.05, while revenue estimate is $5.07B.
Earnings released on 30 Jul 2025
EPS came in at $1.06 surpassing the estimated $0.92 by +15.47%, while revenue for the quarter reached $5.01B , beating expectations by +0.66%.
Dividend declared on 1 Jul 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Aug 2025.
Earnings released on 30 Apr 2025
EPS came in at $1.01 surpassing the estimated $0.91 by +10.50%, while revenue for the quarter reached $4.78B , beating expectations by +2.52%.
Dividend declared on 27 Mar 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 May 2025.
Earnings released on 13 Feb 2025
EPS came in at $1.45 surpassing the estimated $1.26 by +15.08%, while revenue for the quarter reached $5.32B , missing expectations by -0.23%.
Dividend declared on 21 Nov 2024
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 14 Feb 2025.
Earnings released on 30 Oct 2024
EPS came in at $1.14 surpassing the estimated $1.05 by +8.57%, while revenue for the quarter reached $4.86B , missing expectations by -0.11%.
Dividend declared on 18 Sept 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Nov 2024.
Earnings released on 31 Jul 2024
EPS came in at $1.00 surpassing the estimated $0.98 by +2.04%, while revenue for the quarter reached $4.84B , missing expectations by -0.75%.
Dividend declared on 26 Jun 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Aug 2024.
Earnings released on 30 Apr 2024
EPS came in at $0.90 falling short of the estimated $0.91 by -1.10%, while revenue for the quarter reached $4.65B , missing expectations by -3.15%.
Dividend declared on 22 Mar 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 May 2024.
Earnings released on 6 Feb 2024
EPS came in at $1.18 surpassing the estimated $1.07 by +10.28%, while revenue for the quarter reached $5.21B , beating expectations by +2.21%.
Dividend declared on 8 Dec 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Feb 2024.
Earnings released on 31 Oct 2023
EPS came in at $0.99 surpassing the estimated $0.90 by +10.00%, while revenue for the quarter reached $4.82B , beating expectations by +0.37%.
Dividend declared on 22 Sept 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Nov 2023.
Earnings released on 25 Jul 2023
EPS came in at $0.92 surpassing the estimated $0.87 by +5.75%, while revenue for the quarter reached $4.82B , beating expectations by +0.52%.
Dividend declared on 23 Jun 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Aug 2023.
Earnings released on 25 Apr 2023
EPS came in at $0.85 surpassing the estimated $0.79 by +7.59%, while revenue for the quarter reached $4.71B , beating expectations by +1.58%.
Dividend declared on 25 Apr 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Jun 2023.
Earnings released on 30 Jan 2023
EPS came in at $1.31 , while revenue for the quarter reached $4.94B , beating expectations by +0.78%.
Earnings released on 8 Dec 2022
EPS came in at $1.07 , while revenue for the quarter reached $4.48B .
Earnings released on 30 Sept 2022
EPS came in at $1.07 , while revenue for the quarter reached $4.58B .
Earnings released on 31 Mar 2022
EPS came in at $0.86 , while revenue for the quarter reached $4.34B .
Earnings released on 31 Dec 2021
EPS came in at $1.24 , while revenue for the quarter reached $4.59B .
Earnings released on 30 Sept 2021
EPS came in at $1.11 , while revenue for the quarter reached $4.31B .
Earnings released on 30 Jun 2021
EPS came in at $1.28 , while revenue for the quarter reached $4.35B .
Earnings released on 31 Mar 2021
EPS came in at $1.28 , while revenue for the quarter reached $4.35B .
GEHC Stock Performance
Access detailed GEHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.